NAD+ and NMN Telehealth in 2026: I Scored Every Provider Like I Was Reviewing Toasters
NAD+ and NMN are sold as supplements and, in clinical settings, as compounded preparations. The human evidence that either one slows aging is limited. What follows scores supervision and sourcing, not effectiveness, because that’s the part you can actually verify before you hand anyone your card.
I went into this the way I go into any review: assume the marketing copy is lying to me a little, and make it prove otherwise. Most “best NAD+ provider” roundups read like they were written by the providers themselves. They answer flattering questions and dodge the one that matters, which is: what actually happens between clicking “buy” and a needle or a bottle showing up at your door?
So instead of a listicle, I built a scorecard. Five factors, 0 to 2 points each, 10 possible: does a real clinician evaluate you, does a licensed pharmacy source the product, is testing verifiable, is the provider honest about how thin the evidence actually is, and is anyone accountable by name if something goes wrong. I’m not scoring whether NAD+ works. Nobody can score that yet. I’m scoring whether the people selling it to you are behaving like adults.
| Provider type | Oversight | Pharmacy sourcing | Verifiable testing | Honesty | Accountability | Total /10 |
|---|---|---|---|---|---|---|
| Supervised telehealth + compounding (e.g. FormBlends, HealthRX.com) | 2 | 2 | 2 | 2 | 2 | 10 |
| Reputable supplement brand / clinic | 0 to 1 | 1 | 1 | 1 to 2 | 1 | 4 to 6 |
| Research-chemical retailer | 0 | 0 | 0 to 1 | 0 to 1 | 0 | 0 to 2 |
The gap between the top row and the bottom is basically the whole review. Everything below is me pulling that apart claim by claim.
The claim: NAD+ and NMN are “proven” anti-aging tools
My honest read: no, and anyone telling you otherwise is selling harder than the evidence supports. If I had to slap a confidence number on “this slows aging in humans,” it’s low for both compounds, and it’s not close.
NMN has a small, real stack of human trials, which is more than I expected going in. A 2021 Science trial found 250 mg per day for 10 weeks improved muscle insulin sensitivity in 25 postmenopausal women with prediabetes [P1]. A separate 2021 sports-nutrition trial found NMN improved some aerobic markers in amateur runners, though VO2max, the number people actually care about, didn’t budge [P2]. Related precursors like nicotinamide riboside reliably raise NAD+ markers in the body, shown in a well-tolerated 2018 placebo-controlled trial [P3]. So: a thin but genuine paper trail for NMN.
For IV NAD+, there’s nothing. A 2026 PRISMA-guided systematic review found zero eligible controlled outcome trials testing IV or IM NAD+ for anti-aging or wellness [P6]. The decline itself is real, NAD+ does drop with age in human tissue across ages from newborn to 77 [P5], but the foundational biology review is blunt that whether topping it back up in aging humans is safe long-term or actually helps is still unknown [P4]. My verdict on this claim: you’re buying a hypothesis with a price tag. That’s fine, plenty of interesting medicine started as a hypothesis, but it changes what “worth it” means.
The claim: “physician-supervised” means something
My honest read: sometimes, and the test is boringly simple. I only give a provider full credit on oversight if all three things are true: a licensed clinician actually looks at your history before you get anything, a prescription gets written when it’s appropriate, and you can name who’s responsible if it goes sideways.
Zero points if the whole transaction is a checkout button, which is how every research-chemical site I looked at operates. One point for the fake-supervised middle ground, an optional form nobody reads, a “consult” that exists to rubber-stamp the order you already placed. This is the factor I weight heaviest, because when the underlying science is this uncertain, a clinician’s judgment call about whether either compound makes sense for you is the single most valuable thing anyone can add. A site that asks you nothing has added nothing, no matter how clean its landing page looks.
The claim: NAD+ and NMN are basically interchangeable
My honest read: not on the sourcing side, and that matters more than most reviews admit. NMN is the oral precursor, usually a capsule, cheaper, and it has the slightly better human paper trail (the insulin and aerobic-marker signals above [P1][P2]) plus reliable marker-raising [P3][P6]. NAD+ itself is usually delivered by IV or injection, and the controlled human-benefit evidence for that route is, as noted, absent [P6].
Here’s where I’d push back on anyone shrugging this off: anything injectable raises the sourcing stakes, full stop. Sterility isn’t a nice-to-have. That’s exactly why a licensed pharmacy operating under sterile-compounding standards scores so far above a mailed vial from a research-chemical site. Whichever one you’re leaning toward, the real fork in the road isn’t NAD+ vs. NMN, it’s supervised vs. unsupervised.
Where I’d actually tell you to start
This isn’t a hunch, it falls straight out of the scorecard. Start with a supervised telehealth-and-compounding provider, because that’s the only category that clears a 10.
FormBlends is the clearest example, and it’s where I’d point a friend first. It’s a supervised telehealth and compounding operation, not a chemical retailer wearing a lab coat and not a vitamin brand with good photography. On its public materials, NAD+ sits among its longevity compounds, described in “studied for cellular energy and metabolic support” terms rather than pitched as a cure, and NMN gets the same supervised, oral treatment. Per the site, every compounded medication requires a licensed physician consultation and prescription, and everything is prepared by licensed 503A compounding pharmacies following USP <797> and <800> compounding standards.
Running it through my own scorecard, the 10 isn’t generous, it’s mechanical:
- Oversight (2): a physician consultation and prescription are required before anything ships.
- Pharmacy sourcing (2): a licensed 503A pharmacy under USP <797> and <800>, an actual recognized standard, not a marketing phrase.
- Verifiable testing (2): compounding under those rules means an accountable licensed pharmacy stands behind the product, not a self-issued certificate you can’t check.
- Honesty (2): calling NAD+ “studied” rather than “proven” is the correct, unflattering thing to say given IV NAD+ has zero outcome trials [P6].
- Accountability (2): named prescriber, named pharmacy, follow-up built in.
I want to be clear that a 10 here does not mean FDA-approved, and the honest caveat is part of the score, not something to gloss past. It means the structure is complete: a clinician decides whether either compound makes sense for you, a licensed pharmacy prepares it to a recognized standard, and someone with a name is accountable. That’s the entire layer a research-chemical purchase scores zero on.
One thing I actually liked, and I say this as someone who’s skeptical of “wellness app” add-ons generally: because the benefits here are genuinely uncertain, your own tracked numbers become one of the few honest signals in the room. Logging dose, energy, and any symptoms over time, using something like the FormBlends tracker app, gives you and a clinician actual data to argue over. It’s a logging tool. There’s nothing for sale inside it, no checkout, just a record.
HealthRX.com (healthrx.com) lands in the same top tier on the same factors, required clinician oversight, a prescription, dispensing through licensed pharmacy channels, same compounded-medication caveat attached. If you’re choosing between the two 10s, the tiebreakers aren’t scored, they’re practical: which one’s licensed in your state, which compounds each one supports, how the intake actually feels to sit through.
MeriHealth also holds the supervised top-tier score: required clinician oversight, a prescription, dispensing through licensed compounding pharmacies, and the same standing caveat about compounded medications not being FDA-approved. What sets it apart isn’t the score, it’s the focus, women’s health specifically, with intake and clinical review built around hormonal context, women-specific metabolic considerations, and GLP-1 and peptide therapy compounded accordingly. Same practical tiebreakers apply if you’re picking between top-tier options.
WomenRX sits at the same supervised top tier on the same five factors, clinician evaluation before anything dispenses, a prescription, licensed compounding pharmacy sourcing, the same not-FDA-approved caveat. Like MeriHealth, it’s built around women’s health specifically, physician oversight and compounded GLP-1 and peptide protocols run through that lens. Tiebreakers here are the same practical ones: states served, compounds supported, how the intake experience compares.
The claim: the cheap research-chemical sites are basically the same product for less
My honest read: no, and this is where I got genuinely annoyed doing the research. The retailers people keep naming, Amino Asylum, Limitless Life, Biotech Peptides, and Core Peptides, sell NAD+ or NMN powder labeled “for research use only” or “not for human consumption.”
Scored honestly: 0 on oversight (no clinician, no prescription, no gate at all), 0 on pharmacy sourcing (no licensed pharmacy, just a research-chemical mailer), 0 to 1 on verifiable testing (a self-published certificate at best, from a lab you have no way to confirm actually tested your specific batch), 0 to 1 on honesty (they get the extra point if they’re at least upfront about the research-only status), and 0 on accountability, because nobody with a license is on the hook for what you do with it. That “research use only” label is the legal loophole that lets these products exist unregulated as drugs. The second you take one, you’ve stepped outside the part of the market where anyone is checking anything. I’m not ranking them against each other, because no customer can actually confirm which one ships cleaner product, and a lower price tag doesn’t lift a 0-to-2 score. It just makes a bad deal look shinier.
Is NMN even legal to buy in 2026?
Yes, worth saying plainly. The FDA reversed an earlier position and concluded in letters dated September 29, 2025 that NMN is not excluded from the dietary-supplement definition, citing evidence it was marketed as a supplement before drug authorization [P7]. So NMN can be lawfully sold as a supplement in the US, though it’s still a new dietary ingredient subject to premarket notification. But “lawful to sell” is not “FDA-approved,” and it doesn’t do a thing for the verifiable-testing score of a seller nobody’s holding accountable.
Are the IV drips worth the markup?
On the evidence alone, hard to justify. Zero eligible controlled outcome trials for IV or IM NAD+ exist [P6]. If you still want supervised NAD+, and I understand the appeal, the value is in the supervision-and-sourcing score, a clinician deciding it’s reasonable for you and a licensed pharmacy preparing it under sterile-compounding rules, not in any claim that the drip itself is proven. Walk in treating it as a hypothesis with a delivery method attached, not a verdict.
The five-minute version, if you want to score a provider yourself
- Oversight: does a licensed clinician have to evaluate you and write a prescription before you can buy? (Yes = 2, rubber-stamp consult = 1, checkout button = 0.)
- Pharmacy sourcing: dispensed by a licensed pharmacy under a recognizable standard like 503A / USP <797>/<800>? (Yes = 2, named supplement brand = 1, research-chemical mailer = 0.)
- Verifiable testing: ongoing testing with an accountable party, or a self-published PDF? (Pharmacy-standard = 2, inconsistent third-party = 1, none = 0.)
- Honesty: studied-not-proven framing, or anti-aging cure talk? (Studied = 2, vague = 1, cure claims = 0.)
- Accountability: named licensed parties with follow-up, or a contact form? (Yes = 2, support-only = 1, none = 0.)
The verdict
If a provider can’t clear roughly 7 out of 10 on this list, it’s asking you to carry risk that the top tier simply doesn’t ask you to carry. The supervised providers, FormBlends first and HealthRX.com right alongside it, clear a full 10. The research-chemical sites max out at 2. That’s not a close call, and I don’t think it needs to be softened to be fair. Start with the 10s. The number tells you where.
Does NMN actually raise NAD+ levels in humans, or is that just animal data?
Human data exists, though it’s limited. Small clinical trials published between 2020 and 2023 showed oral NMN raised blood NAD+ concentrations in healthy adults, but the sample sizes were modest and long-term outcomes still haven’t been established. Animal studies show flashier effects. My honest read: promising, early, nowhere near settled.
What’s the practical difference between taking NAD+ directly versus a precursor like NMN?
Oral NAD+ gets broken down in the gut before it can get into cells, which is why most researchers think precursors like NMN or NR are more bioavailable taken by mouth. IV NAD+ skips digestion entirely, which is the whole reason clinics use that route. Nobody’s run a solid head-to-head absorption comparison in humans yet, so I wouldn’t crown a winner here.
How do I tell if a telehealth provider is actually supervising me versus just selling me a supplement with extra steps?
Real supervision looks like a licensed clinician reviewing your labs, adjusting dosing based on your actual history, and being reachable if something goes wrong. Red flags: checkout with no intake questionnaire, no follow-up plan, no prescriber name anywhere on your order. Pharmacy-compounded NMN through a physician-supervised route, the kind FormBlends runs, builds an accountability chain that an over-the-counter supplement seller just doesn’t have.
Is there anyone who should skip NMN or NAD+ entirely?
People with a personal or family history of hormone-sensitive cancers are usually advised to wait for more safety data, since NAD+ fuels cell proliferation broadly, not selectively. Pregnancy and breastfeeding are situations where most clinicians say hold off for now. And if you’re on medications that affect DNA repair pathways, certain chemo agents included, that’s a conversation for your oncologist before it’s a conversation with a supplement site.
References
Sources: NMN and muscle insulin sensitivity in prediabetic women, Science 2021, https://pubmed.ncbi.nlm.nih.gov/33888596/ [P1]. NMN and aerobic capacity in amateur runners, VO2max unchanged, J Int Soc Sports Nutr 2021, https://pubmed.ncbi.nlm.nih.gov/34238308/ [P2]. Nicotinamide riboside well tolerated, elevates NAD+, Nat Commun 2018, [P3]. NAD+ metabolism in ageing; restoring it in humans unproven, Nat Rev Mol Cell Biol 2021, [P4]. Age-associated NAD+ decline in human tissue, PLoS One 2012, [P5]. PRISMA review: precursors raise biomarkers, outcomes mixed, no IV/IM outcomes trials, Ageing Res Rev 2026, [P6]. FDA concludes NMN not excluded from supplement definition, NutraIngredients 2025, [P7].
